Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunder Biomedical Tech CoROCO:4115 +0.38%52 Gross Margin % is 16.31% as of Dec. 2025, which is 7% above its 10-year median of 15.31. GuruFocus rates ROCO:4115 with a GF Score™ of 52/100 and a GF Value™ of NT$10.70 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Sunder Biomedical Tech Co ranks worse than 93.18% on this metric.
ROCO:4115's Gross Margin % is ranked worse than 93.18% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs ROCO:4115: 13.60
Sunder Biomedical Tech Co had a gross margin of 16.31% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Sunder Biomedical Tech Co (ROCO:4115) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Sunder Biomedical Tech Co had a gross margin of 16.31% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Sunder Biomedical Tech Co Gross Margin % Related Terms
Sunder Biomedical Tech Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4115 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Sunder Biomedical Tech Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunder Biomedical Tech Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sunder Biomedical Tech Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Sunder Biomedical Tech Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Sunder Biomedical Tech Co (ROCO:4115) has a Gross Margin % of 16.31% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Sunder Biomedical Tech Co and its competitors. This is near median its historical median of 15.31. Over the past decade, Sunder Biomedical Tech Co's Gross Margin % has ranged from 10.12 to 18.53. According to the industry distribution chart, Sunder Biomedical Tech Co ranks #752 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 93.2%.
Is Sunder Biomedical Tech Co's Gross Margin % too high?
Sunder Biomedical Tech Co's current Gross Margin % of 16.31% is near median its 10-year median of 15.31. Over the past 10 years, this metric has ranged from a low of 10.12 to a high of 18.53. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Sunder Biomedical Tech Co's value of 16.31% is 68.7% below this industry median. Based on the distribution chart, Sunder Biomedical Tech Co ranks #752 out of 807 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sunder Biomedical Tech Co has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sunder Biomedical Tech Co ranks #752 out of 807 companies for Gross Margin %. This places Sunder Biomedical Tech Co in the lower half of its industry. The industry median Gross Margin % is 52.03. Sunder Biomedical Tech Co's value of 16.31% is 68.7% below this benchmark. Historically, Sunder Biomedical Tech Co's own Gross Margin % has ranged from 10.12 to 18.53 over the past decade. While the company's 10-year median is 15.31 vs. the industry median of 52.03, Sunder Biomedical Tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunder Biomedical Tech Co's current Gross Margin % of 16.31% is 68.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Sunder Biomedical Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunder Biomedical Tech Co's current Gross Margin % is 16.31%, which is near median its own 10-year median of 15.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$10.70, compared to a current price of NT$7.86 — trading 26.5% below its estimated fair value. The current Gross Margin % is 16.31%, which is near median its 10-year median of 15.31 and 68.7% below the Medical Devices & Instruments industry median of 52.03. Sunder Biomedical Tech Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current Gross Margin % is 16.31% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued.
The current stock price of NT$7.86 is trading 26.5% below its estimated GF Value™ of NT$10.70.
GuruFocus considers Sunder Biomedical Tech Co to be Modestly Undervalued.
Key valuation signals for ROCO:4115:
Gross Margin %: 16.31% (near median its 10-year median of 15.31)
GF Value™: NT$10.70 vs. price of NT$7.86 (26.5% below fair value)
Industry Position: 68.7% below the Medical Devices & Instruments median (#752 of 807)
No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
52GF Score
Get the complete analysis for ROCO:4115
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4115 has been successfully added to your 
